AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leichtmann, G. A.
Right arrow Articles by Sitrin, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leichtmann, G. A.
Right arrow Articles by Sitrin, M. D.
Agricola
Right arrow Articles by Leichtmann, G. A.
Right arrow Articles by Sitrin, M. D.

American Journal of Clinical Nutrition, Vol 54, 548-552, Copyright © 1991 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection

GA Leichtmann, JM Bengoa, MJ Bolt and MD Sitrin
Department of Medicine, University of Chicago, IL.

We compared the intestinal absorption of cholecalciferol and 25- hydroxycholecalciferol in patients with Crohn's disease and resections of the small bowel. Patients were subgrouped into those with small (less than 100 cm), intermediate (100-300 cm), and large (greater than 300 cm) resections. [3H]cholecalciferol or [3H]25- hydroxycholecalciferol were given orally and serial blood samples were taken for measurement of plasma radiolabeled vitamin. Absorption of both forms of the vitamin decreased with extent of resection but 25- hydroxycholecalciferol absorption was always greater than that of cholecalciferol. When compared with normal control subjects, 25- hydroxycholecalciferol absorption in these patients was better maintained than that of cholecalciferol. These data indicate that vitamin D malabsorption reflects the extent of distal small-bowel resection in Crohn's disease. Treatment with oral cholecalciferol is sufficient in those with small or moderate resections but oral 25- hydroxycholecalciferol supplementation may be preferred in those with a severe short-bowel syndrome.


This article has been cited by other articles:


Home page
JPEN J Parenter Enteral NutrHome page
V. Tangpricha, M. Luo, C. Fernandez-Estivariz, L. H. Gu, N. Bazargan, J.-M. Klapproth, S. V. Sitaraman, J. R. Galloway, L. M. Leader, and T. R. Ziegler
Growth Hormone Favorably Affects Bone Turnover and Bone Mineral Density in Patients With Short Bowel Syndrome Undergoing Intestinal Rehabilitation
JPEN J Parenter Enteral Nutr, November 1, 2006; 30(6): 480 - 486.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
H. M. Pappa, C. M. Gordon, T. M. Saslowsky, A. Zholudev, B. Horr, M.-C. Shih, and R. J. Grand
Vitamin D Status in Children and Young Adults With Inflammatory Bowel Disease
Pediatrics, November 1, 2006; 118(5): 1950 - 1961.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M T Abreu, V Kantorovich, E A Vasiliauskas, U Gruntmanis, R Matuk, K Daigle, S Chen, D Zehnder, Y-C Lin, H Yang, et al.
Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density
Gut, August 1, 2004; 53(8): 1129 - 1136.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
K V Haderslev, P B Jeppesen, H A Sorensen, P B Mortensen, and M Staun
Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection
Gut, May 1, 2003; 52(5): 653 - 658.
[Abstract] [Full Text]


Home page
GutHome page
K V Haderslev, P B Jeppesen, P B Mortensen, and M Staun
Absorption of calcium and magnesium in patients with intestinal resections treated with medium chain fatty acids
Gut, June 1, 2000; 46(6): 819 - 823.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
I. Bjarnason
Metabolic bone disease in patients with inflammatory bowel disease
Rheumatology, September 1, 1999; 38(9): 801 - 804.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The American Society for Nutrition